Nemaura Medical Inc (NASDAQ:NMRD) issued its quarterly earnings results on Tuesday. The company reported $0.00 EPS for the quarter, Zacks reports.
About Nemaura Medical
Nemaura Medical, Inc is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company’s focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source.
What are top analysts saying about Nemaura Medical Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Nemaura Medical Inc and related companies.